Roberta Budriesi
About
In The Last Decade
Roberta Budriesi
150 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 134
- Molecular Biology 1.1k
- Organic Chemistry 1.0k
- Pharmacology 310
- Plant Science 250
- Biochemistry 217
Countries citing papers authored by Roberta Budriesi
This map shows the geographic impact of Roberta Budriesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Budriesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Budriesi more than expected).
Fields of papers citing papers by Roberta Budriesi
This network shows the impact of papers produced by Roberta Budriesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Budriesi. The network helps show where Roberta Budriesi may publish in the future.
Co-authorship network of co-authors of Roberta Budriesi
This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Budriesi. A scholar is included among the top collaborators of Roberta Budriesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Budriesi. Roberta Budriesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 25 | |
| 7 | 14 | |
| 8 | 90 | |
| 9 | 23 | |
| 10 | 3 | |
| 11 | 2 | |
| 12 | 23 | |
| 13 | 20 | |
| 14 | 48 | |
| 15 | 1 | |
| 16 | Development of Potent and Selective Peripheral 5-HT3 Receptor Agonists and Antagonists, Keystones of a New Therapeutic Strategy to Cardiac Diseases | 1 |
| 17 | Structure-activity relationship studies on the potent multidrug resistance (MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5-[(anthr-9-yl)methylamino] pentanenitrile (MM36) | 1 |
| 18 | Cyano-NNO-azoxy Analogs of Nifedipine | 2 |
| 19 | 4-Heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect | 2 |
| 20 | Le origini di Venezia | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.